Skip to main content
. 2011 Mar 11;183(12):1680–1688. doi: 10.1164/rccm.201002-0254OC

TABLE 1.

COMPARISON OF DEMOGRAPHIC CHARACTERISTICS AMONG SUBJECTS WITH CHRONIC BERYLLIUM DISEASE, SUBJECTS WITH BERYLLIUM SENSITIZATION, AND CONTROL SUBJECTS

Total Control Subjects BeS CBD
(n = 386) (n = 255) (n = 70) (n = 61) P Value
Median age, yr (range)* 67 (41–89) 67 (41–89) 65 (45–84) 65 (49–86)
Sex, n (%)
 Male 341 (88.3%) 230 (90.2%) 55 (78.6%) 56 (91.8%)
 Female 45 (11.7%) 25 (9.8%) 15 (21.4%),§ 5 (8.2%)§ 0.009, 0.036§
Race, n (%)
 White 377 (97.7%) 252 (98.8%) 68 (97.1%) 57 (93.4%)
 African American 9 (2.3%) 3 (1.2%) 2 (2.9%) 4 (6.6%)§ 0.028§
Ethnicity, n (%)
 Hispanic 24 (6.2%) 11 (4.3%) 8 (11.4%) 5 (8.2%) 0.039
 Non-Hispanic 362 (93.8%) 244 (95.7%) 62 (88.6%) 56 (91.8%)
Smoking status, n (%)
 Current 23 (6.0%) 13 (5.1%) 8 (11.4%),§ 2 (3.3%)§ 0.094, 0.104§
 Former 203 (52.6%) 135 (52.9%) 34 (48.6%) 34 (55.7%)
 Never 160 (41.4%) 107 (42.0%) 28 (40.0%) 25 (41.0%)
Year of hire, median (range)* 1969 (1952–1998) 1968 (1952–1993) 1972 (1952–1998) 1969 (1952–1990)
Years at facility, median (range)* 15.0 (0.2–40.7) 15.8 (0.2–40.7) 12.6 (0.5–33.7) 16.8 (1.0–40.0) 0.020

Definition of abbreviations: BeS = beryllium sensitization; CBD = chronic beryllium disease.

*

Compared using Kruskal-Wallis test followed by pair-wise Mann-Whitney tests when significant.

Compared using chi-square or Fisher's exact method.

Comparison between BeS and control subjects.

§

Comparison between BeS and CBD.

Comparison between CBD and control subjects.